Compare CMMB & ORIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMMB | ORIO |
|---|---|---|
| Founded | 2004 | N/A |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9M | 20.5M |
| IPO Year | 2023 | 2014 |
| Metric | CMMB | ORIO |
|---|---|---|
| Price | $2.85 | $1.03 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | ★ 98.2K | 83.2K |
| Earning Date | 05-21-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.67 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $74.52 |
| Revenue Next Year | N/A | $5.07 |
| P/E Ratio | $67.75 | ★ $4.93 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.35 | $0.61 |
| 52 Week High | $3.55 | $1.40 |
| Indicator | CMMB | ORIO |
|---|---|---|
| Relative Strength Index (RSI) | 84.13 | 63.88 |
| Support Level | $1.47 | $0.82 |
| Resistance Level | $2.86 | $1.11 |
| Average True Range (ATR) | 0.21 | 0.10 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 87.54 | 74.27 |
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
Orion Digital Corp is a financial technology company operating digital platforms across wealth and payments, supported by a consumer lending business in Canada. The Company's Wealth platform, Intelligent Investing, provides long-term investment solutions to the Canadian market. It also operates a consumer lending business in Canada. Its Payments business is conducted through its wholly owned subsidiary, which provides issuer processing, program management, and regulated payment orchestration services across Europe. The Company operates in Canada and Europe, with Canada generating the majority of its revenue.